Author:
Zuo Qian,Xu Ding-qiao,Yue Shi-jun,Fu Rui-jia,Tang Yu-ping
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,General Medicine
Reference116 articles.
1. Zhan X, Wu H, Wu H, et al. Metabolites from Bufo gargarizans (Cantor, 1842): a review of traditional uses, pharmacological activity, toxicity and quality control. J Ethnopharmacol 2020;246:112178.
2. Horioka K, Ohuchida K, Sada M, et al. Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer. Int J Oncol 2016;48:1499–1508.
3. Wu Q, Wang SP, Sun XX, et al. HuaChanSu suppresses tumor growth and interferes with glucose metabolism in hepatocellular carcinoma cells by restraining hexokinase-2. Int J Biochem Cell Biol 2022;142:106123.
4. Wei X, Si N, Zhang Y, et al. Evaluation of bufadienolides as the main antitumor components in cinobufacin injection for liver and gastric cancer therapy. PLoS One 2017;12:e0169141.
5. Li QW, Ma LF, Liu CB, et al. Cinobufacini inhibits the development of pancreatic cancer cells through the TGFβ/Smads pathway of pancreatic stellate cells. Evid Based Complement Alternat Med 2022;2022:3719857.